Skip to main content
. Author manuscript; available in PMC: 2022 Mar 11.
Published in final edited form as: J Med Chem. 2021 Feb 12;64(5):2691–2704. doi: 10.1021/acs.jmedchem.0c01922

Figure 1:

Figure 1:

Currently known HDAC6 inhibitors. The structural features involve a hydroxamic acid which is required for Zn2+ binding, and a linker that connects the hydroxamic acid to a cap group. a) Currently known inhibitors achieved HDAC6 selectivity by replacing the benzene substituent on SAHA with a bulkier, usually hydrophobic cap group. b) Previous studies showed compound 1 is a nM inhibitor against HDAC6 exhibiting limited selectivity c) Current studies show TO-317 adopts a rotatable cap group with two aromatic substituents that occupy the HDAC6 surface facilitating specific residue interactions.

*IC50 values were determined using an activity-based electrophoretic mobility shift assay (EMSA) by Nanosyn Inc., USA.